Inducible Clindamycin-Resistant Staphylococcus aureus Strains in Africa: A Systematic Review

Figure 4

The prevalence of iMLSB phenotype in MRSA strains in African countries (ordered using study period: Libya (2007), Tanzania (2008 to 2015), Sudan (2009 to 2018), Nigeria (2012 to 2018), Egypt (2016 to 2019), Côte d’Ivoire (2017), and Ethiopia (2017)). Abbreviations: iMLSB, inducible macrolide-lincosamide-streptogramin B; MRSA, methicillin-resistant Staphylococcus aureus.